Although combinatorial therapy in 344SQ and 393P tumors exhibited differences in tumor growth and metastatic phenotypes, both tumor types exhibited similar changes in CD8+ T-cell patterns at the point of sensitivity and resistance to the respective drug treatments, suggesting a mutual secondary immune cell infiltrate that promotes resistance following CD8+ T-cell infiltration. Here, CD8A is linked to neoplasm.